Ferring is here to help people around the world build families and live better lives.
Headquartered in Switzerland, Ferring Pharmaceuticals is a research-driven, specialty biopharmaceutical group active in global markets. The company identifies, develops and markets innovative products in the areas of reproductive medicine and maternal health, urology and gastroenterology. Ferring has its own operating subsidiaries in nearly 60 countries and markets its treatments in 110 countries.
Community guidelines available here: https://re.ferring.com/Ferring-LinkedIn-Community-Guidelines
Headquartered in Switzerland, Ferring Pharmaceuticals is a research-driven, specialty biopharmaceutical group active in global markets. The company identifies, develops and markets innovative products in the areas of reproductive medicine and maternal health, urology and gastroenterology. Ferring has its own operating subsidiaries in nearly 60 countries and markets its treatments in 110 countries.
Community guidelines available here: https://re.ferring.com/Ferring-LinkedIn-Community-Guidelines
Location: United States, Florida, Fruit Cove
Employees: 5001-10000
Phone: +41 58 301 00 00
Founded date: 1950
Mentions in press and media 17
| Date | Title | Description |
| 06.05.2025 | Genetic Analysis Secures NOK 12.8 Million Through Directed Share Issue | In a strategic move to bolster its financial footing, Genetic Analysis AS (GA) has announced a directed share issue, raising NOK 12.8 million. This decision, driven by commitments from existing major shareholders, marks a significant step f... |
| 05.05.2025 | Genetic Analysis announces placement of a directed share issue of NOK 12.8 million | Genetic Analysis announces placement of a directed share issue of NOK 12.8 million Mon, May 05, 2025 08:00 CET Report this content NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, THE UNITED KINGDO... |
| 05.05.2025 | Correction: Genetic Analysis announces placement of a directed share issue of NOK 12.8 million | Correction: Genetic Analysis announces placement of a directed share issue of NOK 12.8 million Mon, May 05, 2025 09:45 CET Report this content Correction due to an incorrect date in the preamble regarding the calculation of the subscription... |
| 26.02.2025 | Genetic Analysis AS publishes year-end report 2024 | Genetic Analysis AS publishes year-end report 2024 Wed, Feb 26, 2025 08:00 CET Report this content OSLO, NORWAY – 26 February 2025: Genetic Analysis AS (the "Company", Ticker: GEAN) hereby publishes the year-end report for the per... |
| 20.12.2024 | GENETIC ANALYSIS AND FERRING PHARMACEUTICALS ANNOUNCE A COLLABORATION TO DEVELOP A NEW MICROBIOME RAPID DIAGNOSTIC TEST | GENETIC ANALYSIS AND FERRING PHARMACEUTICALS ANNOUNCE A COLLABORATION TO DEVELOP A NEW MICROBIOME RAPID DIAGNOSTIC TEST Fri, Dec 20, 2024 17:12 CET Report this content Collaboration announced to develop and launch a new rapid microbiome-bas... |
| 31.07.2024 | 2024 Zhongshan Global Investment Promotion Conference Opened, Presenting Excellent Business Environment to the World | ZHONGSHAN, CHINA – Media OutReach Newswire – 31 July 2024 – On July 30, the one-month anniversary of the official opening of the Shenzhen-Zhongshan Link, a mega cross-sea project, the 2024 Zhongshan Global Investment Promotion Conference wa... |
| 15.04.2024 | Amid threats to IVF, National Infertility Awareness Week® Brings Awareness Activities Across the Country | National Infertility Awareness Week® take place April 21 through April 27, 2024. RESOLVE: The National Infertility Association will recognize National Infertility Awareness Week®, April 21 through April 27, 2024. The movement brings togethe... |
| 21.03.2024 | Advances in Digitalization Presented at the 10th Annual Genedata Biopharma Partner Symposium | Digitalizing Biopharma R&D: The Genedata Biopharma Platform is the #1 enterprise software system for achieving operational excellence in biopharma R&D. Leading scientific, IT, and business innovators in the biopharma industry showca... |
| 07.11.2023 | Unveiling the hidden struggles: Survey reveals worrying knowledge gap and emotional toll of infertility amidst record-low birth rates in Asia | A survey conducted in seven Asian markets, including Taiwan, revealed that respondents, on average, spent 6.8 years on their fertility journey, with 3.6 years dedicated to trying to conceive naturally.1,2 In Indonesia, Japan, Korea, Singapo... |
| 07.11.2023 | Unveiling the hidden struggles: Survey reveals worrying knowledge gap and emotional toll of infertility amidst record-low birth rates in Asia | A survey conducted in seven Asian markets, including Singapore, revealed that respondents, on average, spent 6.8 years on their fertility journey, with 3.6 years dedicated to trying to conceive naturally.1,2 In Indonesia, Japan, Korea, Sing... |
Show more